These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2574560)

  • 1. [Efficacy and tolerability of tertatolol in the treatment of mild to moderate arterial hypertension. Results of a French multicenter study with 2,338 patients treated over one year].
    Herpin D; Piron J; Bajou B; Lecasble M
    Ann Cardiol Angeiol (Paris); 1989 Oct; 38(8):503-7. PubMed ID: 2574560
    [No Abstract]   [Full Text] [Related]  

  • 2. [Renal effects of intravenous tertatolol in essential arterial hypertension].
    Chaignon M; Brouard R; Lucsko M; Guédon J
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1219-22. PubMed ID: 1979729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methyldopa (Aldomet) in combination with timolol (Blocadren) in the treatment of hypertension.
    Seedat YK
    Curr Ther Res Clin Exp; 1976 Jul; 20(1):10-8. PubMed ID: 8279
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative study of metoprolol and trichlormethiazide in hypertension.
    Stokkeland OM; Sangvik K; Ditlefsen EM
    Curr Ther Res Clin Exp; 1975 Dec; 18(6):755-68. PubMed ID: 2449
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metoprolol, a new cardioselective beta blocking agent in the treatment of arterial hypertension].
    Pedersen OL
    Ugeskr Laeger; 1975 Sep; 137(39):2274-6. PubMed ID: 241148
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H; Schmidt J; Derendorf H
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of bevantolol hydrochloride in patients with severe hypertension. The Cooperative Study Group on Bevantolol in Japan.
    Noshiro T; Miura Y; Yoshinaga K; Iimura O; Inagaki Y; Saruta T; Ishii M; Yamazaki N; Arakawa K
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):240-5. PubMed ID: 7620695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobanum treatment in mild and medium severity hypertension.
    Udvarhelyi A
    Ther Hung; 1986; 34(3):171-4. PubMed ID: 2894722
    [No Abstract]   [Full Text] [Related]  

  • 9. Age dependence of therapy result and risk in the treatment of arterial hypertension?
    Höffler D; Morgenstern HO
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S184-8. PubMed ID: 11527125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Tertatolol International Multicenter Study (T.I.M.S.). Predicting factors of an efficient therapy.
    Agnes E; Vandermercken C; Prost JF; Safar ME
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):296S-302S. PubMed ID: 2573379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of the effectiveness and acceptability of tertatolol 5 mg and acebutolol 400mg in the treatment of mild arterial hypertension].
    Gallet M; Lestaevel M; Lopez M; Manchon J; Brodsky D
    Ann Med Interne (Paris); 1987; 138 Suppl 1():31-4. PubMed ID: 2884914
    [No Abstract]   [Full Text] [Related]  

  • 12. [Betaxolol versus nifedipine in the treatment of essential hypertension].
    Steiner A; Hany S; Bättig B; Jenni R; Troesch M; Willimann P; Graf A; Leutenegger F; Angehrn V; Beck G
    Schweiz Rundsch Med Prax; 1988 Oct; 77(41):1101-3. PubMed ID: 2907178
    [No Abstract]   [Full Text] [Related]  

  • 13. European experience with artex: the Tertatolol International Multicentre Study (TIMS).
    Laher MS
    Cardiology; 1993; 83 Suppl 1():25-31. PubMed ID: 7903212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled trial on three beta-blockers: antihypertensive efficacy and effect on the hypertensive heart disease.
    Pupita F; Ansuini R; Belogi M; Pupita G; Gaggi S
    Int J Clin Pharmacol Res; 1985; 5(6):439-45. PubMed ID: 2869001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term studies of bucindolol in mild to moderate hypertension: efficacy, safety, and exercise responses.
    Rosendorff C; Goodman C; Coull A
    J Clin Pharmacol; 1985 Apr; 25(3):233-6. PubMed ID: 2860134
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypotensive action of ICI66.082, a new beta-adrenergic blocking agent.
    Hansson L; Henningsen NC; Karlberg B; Aberg H; Jameson S; Malmcrona R; Hersvall C
    Int J Clin Pharmacol; 1974 Oct; 10(3):206-11. PubMed ID: 4154313
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study of the beta-blocker chlorpropanol (tobanum) in hypertension patients].
    Sirakova V; Penkov N; Kaponov Kh
    Vutr Boles; 1986; 25(1):35-41. PubMed ID: 2872751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of different beta-receptor blockers on the respiratory function of patients with chronic obstructive pulmonary disease and arterial hypertension].
    Dorow P
    Arzneimittelforschung; 1987 Dec; 37(12):1370-2. PubMed ID: 2896506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of clinical safety and efficacy of tertatolol.
    Vivet P
    Cardiology; 1993; 83 Suppl 1():41-50. PubMed ID: 7903214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular response to adrenergic stimulation during treatment with tertatolol. A new non-cardioselective beta-blocking agent in primary hypertensive patients.
    Fasano ML; Gaeta I; De Simone G; Iannuzzi R; Ferrara LA
    Jpn Heart J; 1991 Jul; 32(4):435-44. PubMed ID: 1683411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.